What is the Price of survival in Hodgkin's lymphoma? Long-term follow-up of cured patients

Miltényi Zsófia, Keresztes Katalin, Végh Judit, Székely György, Illés Árpád

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The paper investigates the late complications of cured Hodgkin's lymphoma (HL) patients. Ninety cured HL patients between 1975 and 1994 were examined. The mean ages of patients at the time of diagnosing HL, and the median period of survival after diagnosis were 32 (11-70) years and 18 (10-30) years, respectively. Among the 90 patients, 73 are still alive, there is no information about 9 and 8 patients died, second malignant disease being the cause of death in 4 of them. Relapse was observed in 24 patients, of which 19 recovered after relapse and were included in the study then. Five patients had late relapse. In 38% of patients, cardiovascular changes, while in 32% pulmonary and pleural damages were observed. Disorders of the thyroid gland, overwhelmingly hypothyroidism, were found in 24%. Less frequently, a second malignant tumour (9%), damage to the skin, musculature, bones and genitourinary system (6%) as well as the gastrointestinal system could be detected. Treatment based on modern therapeutic approaches is expected to decrease the incidence of complications. Still the aim is early detection through close patient follow-up, which may improve the quality of life and decrease mortality as a result.

Original languageEnglish
Pages (from-to)178-183
Number of pages6
JournalHematological Oncology
Volume25
Issue number4
DOIs
Publication statusPublished - Dec 2007

Fingerprint

Hodgkin Disease
Survival
Recurrence
Urogenital System
Hypothyroidism
Cause of Death
Thyroid Gland
Quality of Life
Bone and Bones
Lung
Skin
Mortality
Incidence
Therapeutics

Keywords

  • Hodgkin's lymphoma
  • Late complications
  • Treatment

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

What is the Price of survival in Hodgkin's lymphoma? Long-term follow-up of cured patients. / Zsófia, Miltényi; Katalin, Keresztes; Judit, Végh; György, Székely; Árpád, Illés.

In: Hematological Oncology, Vol. 25, No. 4, 12.2007, p. 178-183.

Research output: Contribution to journalArticle

Zsófia, Miltényi ; Katalin, Keresztes ; Judit, Végh ; György, Székely ; Árpád, Illés. / What is the Price of survival in Hodgkin's lymphoma? Long-term follow-up of cured patients. In: Hematological Oncology. 2007 ; Vol. 25, No. 4. pp. 178-183.
@article{bdec0466999b4a9383679aff7198ab4a,
title = "What is the Price of survival in Hodgkin's lymphoma? Long-term follow-up of cured patients",
abstract = "The paper investigates the late complications of cured Hodgkin's lymphoma (HL) patients. Ninety cured HL patients between 1975 and 1994 were examined. The mean ages of patients at the time of diagnosing HL, and the median period of survival after diagnosis were 32 (11-70) years and 18 (10-30) years, respectively. Among the 90 patients, 73 are still alive, there is no information about 9 and 8 patients died, second malignant disease being the cause of death in 4 of them. Relapse was observed in 24 patients, of which 19 recovered after relapse and were included in the study then. Five patients had late relapse. In 38{\%} of patients, cardiovascular changes, while in 32{\%} pulmonary and pleural damages were observed. Disorders of the thyroid gland, overwhelmingly hypothyroidism, were found in 24{\%}. Less frequently, a second malignant tumour (9{\%}), damage to the skin, musculature, bones and genitourinary system (6{\%}) as well as the gastrointestinal system could be detected. Treatment based on modern therapeutic approaches is expected to decrease the incidence of complications. Still the aim is early detection through close patient follow-up, which may improve the quality of life and decrease mortality as a result.",
keywords = "Hodgkin's lymphoma, Late complications, Treatment",
author = "Milt{\'e}nyi Zs{\'o}fia and Keresztes Katalin and V{\'e}gh Judit and Sz{\'e}kely Gy{\"o}rgy and Ill{\'e}s {\'A}rp{\'a}d",
year = "2007",
month = "12",
doi = "10.1002/hon.824",
language = "English",
volume = "25",
pages = "178--183",
journal = "Hematological Oncology",
issn = "0278-0232",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - What is the Price of survival in Hodgkin's lymphoma? Long-term follow-up of cured patients

AU - Zsófia, Miltényi

AU - Katalin, Keresztes

AU - Judit, Végh

AU - György, Székely

AU - Árpád, Illés

PY - 2007/12

Y1 - 2007/12

N2 - The paper investigates the late complications of cured Hodgkin's lymphoma (HL) patients. Ninety cured HL patients between 1975 and 1994 were examined. The mean ages of patients at the time of diagnosing HL, and the median period of survival after diagnosis were 32 (11-70) years and 18 (10-30) years, respectively. Among the 90 patients, 73 are still alive, there is no information about 9 and 8 patients died, second malignant disease being the cause of death in 4 of them. Relapse was observed in 24 patients, of which 19 recovered after relapse and were included in the study then. Five patients had late relapse. In 38% of patients, cardiovascular changes, while in 32% pulmonary and pleural damages were observed. Disorders of the thyroid gland, overwhelmingly hypothyroidism, were found in 24%. Less frequently, a second malignant tumour (9%), damage to the skin, musculature, bones and genitourinary system (6%) as well as the gastrointestinal system could be detected. Treatment based on modern therapeutic approaches is expected to decrease the incidence of complications. Still the aim is early detection through close patient follow-up, which may improve the quality of life and decrease mortality as a result.

AB - The paper investigates the late complications of cured Hodgkin's lymphoma (HL) patients. Ninety cured HL patients between 1975 and 1994 were examined. The mean ages of patients at the time of diagnosing HL, and the median period of survival after diagnosis were 32 (11-70) years and 18 (10-30) years, respectively. Among the 90 patients, 73 are still alive, there is no information about 9 and 8 patients died, second malignant disease being the cause of death in 4 of them. Relapse was observed in 24 patients, of which 19 recovered after relapse and were included in the study then. Five patients had late relapse. In 38% of patients, cardiovascular changes, while in 32% pulmonary and pleural damages were observed. Disorders of the thyroid gland, overwhelmingly hypothyroidism, were found in 24%. Less frequently, a second malignant tumour (9%), damage to the skin, musculature, bones and genitourinary system (6%) as well as the gastrointestinal system could be detected. Treatment based on modern therapeutic approaches is expected to decrease the incidence of complications. Still the aim is early detection through close patient follow-up, which may improve the quality of life and decrease mortality as a result.

KW - Hodgkin's lymphoma

KW - Late complications

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=37649025339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37649025339&partnerID=8YFLogxK

U2 - 10.1002/hon.824

DO - 10.1002/hon.824

M3 - Article

VL - 25

SP - 178

EP - 183

JO - Hematological Oncology

JF - Hematological Oncology

SN - 0278-0232

IS - 4

ER -